You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Nanoliposomal irinotecan

Showing 1 - 25 of 1,106
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Nanoliposomal Irinotecan With Fluorouracil and Folinic Acid in

Not yet recruiting
  • Pancreatic Adenocarcinoma Metastatic
    • Pessac, France
      CHU Bordeaux
    Aug 17, 2023

    Pancreatic Ductal Adenocarcinoma Trial in United States (Onvansertib, Nanoliposomal irinotecan, Leucovorin)

    Recruiting
    • Pancreatic Ductal Adenocarcinoma
    • Phoenix, Arizona
    • +5 more
    Dec 15, 2022

    Metastatic Pancreatic Cancer Trial (nanoliposomal irinotecan, spleen irradiation)

    Not yet recruiting
    • Metastatic Pancreatic Cancer
    • nanoliposomal irinotecan
    • spleen irradiation
    • (no location specified)
    May 8, 2022

    Peritoneal Carcinomatosis, Peritoneal Metastases, Colorectal Cancer Trial in Ghent (PIPAC with Nal-IRI)

    Recruiting
    • Peritoneal Carcinomatosis
    • +7 more
    • PIPAC with Nal-IRI
    • Ghent, East-Flanders, Belgium
      UZ Ghent
    Dec 28, 2022

    Metastatic Pancreatic Cancer Trial (Olaptesed pegol)

    Not yet recruiting
    • Metastatic Pancreatic Cancer
    • Olaptesed pegol
    • (no location specified)
    Jul 19, 2022

    Colorectal Adenocarcinoma, Gastric Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma Trial in Atlanta (Nanoliposomal

    Recruiting
    • Colorectal Adenocarcinoma
    • +13 more
    • Nanoliposomal Irinotecan
    • Trifluridine and Tipiracil Hydrochloride
    • Atlanta, Georgia
    • +2 more
    Jan 6, 2023

    Peritoneal Cancer, Pseudomyxoma Peritonei, Mucinous Adenocarcinoma Trial in Lexington, Stony Brook (nanoliposomal irinotecan)

    Completed
    • Peritoneal Cancer
    • +7 more
    • nanoliposomal irinotecan
    • Lexington, Kentucky
    • +1 more
    May 5, 2022

    Biliary Tract Cancer Trial in United States (Nivolumab, Nanoliposomal-Irinotecan, 5-Fluorouracil)

    Active, not recruiting
    • Biliary Tract Cancer
    • Ann Arbor, Michigan
    • +4 more
    Oct 6, 2022

    Advanced Biliary Tract Cancer Trial in Washington, Indianapolis, Saint Louis (Nanoliposomal Irinotecan, Leucovorin,

    Recruiting
    • Advanced Biliary Tract Cancer
    • Nanoliposomal Irinotecan
    • +2 more
    • Washington, District of Columbia
    • +2 more
    Oct 29, 2021

    Refractory Solid Tumors Trial in Taichung, Tainan (Nanoliposomal Irinotecan)

    Active, not recruiting
    • Refractory Solid Tumors
    • Nanoliposomal Irinotecan
    • Taichung, Taiwan
    • +1 more
    Sep 16, 2021

    Metastatic Biliary Tract Cancer Trial in Seoul (Onivyde, 5-FU/LV)

    Completed
    • Metastatic Biliary Tract Cancer
    • Seoul, Korea, Republic of
      Asan Medical Center
    Aug 22, 2022

    Malignant Solid Tumor Trial in United States (drug, other, procedure)

    Active, not recruiting
    • Malignant Solid Neoplasm
    • Baltimore, Maryland
    • +5 more
    Nov 8, 2022

    High Grade Glioma Trial in San Francisco (nanoliposomal irinotecan)

    Active, not recruiting
    • High Grade Glioma
    • nanoliposomal irinotecan
    • San Francisco, California
      University of California, San Francisco
    Oct 26, 2021

    Tolerability of Liposomal Irinotecan

    Active, not recruiting
    • Metastatic Pancreatic Ductal Adenocarcinoma
    • Onivyde® + 5-FULV
    • Edegem, Belgium
      Antwerp University Hosptital
    Jan 31, 2022

    Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal

    Completed
    Has Results
    • Platinum-Resistant Fallopian Tube Carcinoma
    • +8 more
    • Bevacizumab
    • Irinotecan Sucrosofate
    • Chicago, Illinois
      Northwestern University
    Dec 21, 2022

    Head & Neck Cancer Trial in Taichung, Tainan, Taipei (nanoliposomal irinotecan)

    Active, not recruiting
    • Head & Neck Cancer
    • nanoliposomal irinotecan
    • Taichung, Taiwan
    • +3 more
    Mar 25, 2021

    GEP-NET Trial in Taiwan (nanoliposomal irinotecan plus carboplatin)

    Not yet recruiting
    • GEP-NET
    • nanoliposomal irinotecan plus carboplatin
    • Kaohsiung, Taiwan
    • +5 more
    May 17, 2022

    Metastatic Pancreatic Ductal Adenocarcinoma Trial in Belgium (Nanoliposomal irinotecan, 5 FU, Leucovorin)

    Recruiting
    • Metastatic Pancreatic Ductal Adenocarcinoma
    • Nanoliposomal irinotecan
    • +3 more
    • Brugge, West-Vlaanderen, Belgium
    • +11 more
    Jul 25, 2022

    Pancreatic Cancer Trial in Australia, Spain, United States (nal-IRI, 5 fluorouracil, Leucovorin)

    Completed
    Has Results
    • Pancreatic Cancer
    • Mobile, Alabama
    • +35 more
    Oct 7, 2022

    Pancreatic Adenocarcinoma Trial in Seattle (Gemcitabine, nab paclitaxel, Onivyde)

    Recruiting
    • Pancreatic Adenocarcinoma
    • Seattle, Washington
      Virginia mason medical Center
    Jan 25, 2021

    Recurrent Solid Tumor, Recurrent Ewing Sarcoma, Recurrent Hepatoblastoma Trial in Canada, United States (Onivyde, Talazoparib,

    Recruiting
    • Recurrent Solid Tumor
    • +21 more
    • Palo Alto, California
    • +8 more
    Jun 7, 2022

    Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in United States (Fluorouracil, Gemcitabine,

    Recruiting
    • Metastatic Pancreatic Adenocarcinoma
    • Stage IV Pancreatic Cancer AJCC v8
    • Boise, Idaho
    • +42 more
    Jun 8, 2022

    Locally Advanced Unresectable Gastric Adenocarcinoma, Metastatic Gastroesophageal Junction Adenocarcinoma, Metastatic

    Withdrawn
    • Locally Advanced Unresectable Gastric Adenocarcinoma
    • +5 more
    • Liposomal Irinotecan
    • +3 more
    • Los Angeles, California
      USC / Norris Comprehensive Cancer Center
    Mar 25, 2020

    Solid Tumors, ER/PR Positive Breast Cancer, Triple Negative Breast Cancer Trial in United States (Ferumoxytol, MM-398)

    Completed
    Has Results
    • Solid Tumors
    • +3 more
    • Scottsdale, Arizona
    • +6 more
    Nov 15, 2019

    Metastatic Gastric Adenocarcinoma, Second Line, Chemo Trial (nal-IRI /Experimental, Ramucirumab /Experimental,

    Not yet recruiting
    • Metastatic Gastric Adenocarcinoma
    • +2 more
    • nal-IRI /Experimental
    • +2 more
    • (no location specified)
    Jun 25, 2023